These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 484820)

  • 1. [Coagulation problems associated with massive blood transfusions. An experimental study (author's transl)].
    Witzke G; Abdulla W
    Anaesthesist; 1979 Jul; 28(7):322-7. PubMed ID: 484820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation disorders in massively injured patients.
    Harke H; Rahman S
    Prog Clin Biol Res; 1982; 108():213-24. PubMed ID: 6817337
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation findings in rats with experimental hypersplenism and their changes after splenectomy and after administration of adrenaline.
    Pudlák P; Farská I; Brabec V; Pospísilová V
    Thromb Diath Haemorrh; 1970 Jun; 23(3):593-600. PubMed ID: 5432195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for transfusion therapy. Volume substitution, raising oxygen transport capacity and replacement of clotting factors (author's transl)].
    Abdulla W; Frey R; Witzke G
    MMW Munch Med Wochenschr; 1979 Aug; 121(32-33):1051-4. PubMed ID: 112468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation disorders in severely and critically injured patients.
    Avikainen V
    Ann Chir Gynaecol; 1977; 66(6):269-77. PubMed ID: 603216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.
    Buchta C; Felfernig M; Höcker P; Macher M; Körmöczi GF; Quehenberger P; Heinzl H; Knöbl P
    Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days.
    Sidhu RS; Le T; Brimhall B; Thompson H
    J Clin Apher; 2006 Dec; 21(4):224-6. PubMed ID: 16607628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
    Baklaja F; Cvetković V; Stajić M; Krivokapić L
    Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostics and therapy of hemolytic-hemorrhagic transfusion incidents].
    Brüster H
    Zentralbl Neurochir; 1972; 33(1):63-8. PubMed ID: 5072151
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemostasis disorders after transfusions].
    Weissbach G; Domula M; Lenk H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):345-66. PubMed ID: 6169596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bleeding complications in acute myeloblastic leukemia (author's transl)].
    Sutor AH
    Klin Padiatr; 1979 Mar; 191(2):217-24. PubMed ID: 286849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
    Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
    Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care of the critically ill child: the problem of disseminated intravascular coagulation.
    Hathaway WE
    Pediatrics; 1970 Nov; 46(5):767-73. PubMed ID: 5481077
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bleeding times in haemophilia patients treated with lyophilised antihaemophilic globulin (AHG) (author's transl)].
    Sutor AH; Jesdinsky-Buscher CJ
    Dtsch Med Wochenschr; 1976 Nov; 101(47):1715-9. PubMed ID: 991757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation properties of fresh-frozin canine plasma during prolonged storage.
    Greene CE; Beck BB
    Am J Vet Res; 1980 Jan; 41(1):147-50. PubMed ID: 7362120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood plasma fractions for the treatment of coagulation disorders. II. Production and clinical use of factor VIII containing preparations].
    Richter K
    Z Gesamte Inn Med; 1967 Aug; 22(15):451-6. PubMed ID: 5592694
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive blood transfusion therapy.
    Corazza ML; Hranchook AM
    AANA J; 2000 Aug; 68(4):311-4. PubMed ID: 11125603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proceedings: Coagulation changes following massive blood-transfusion (author's transl)].
    Heene DL; Lasch HG
    Thoraxchir Vask Chir; 1973 Oct; 21(5):344-50. PubMed ID: 4544417
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital combined deficiency of factor V and factor 8. A case report and the effect of transfusion of normal plasma and hemophilic blood.
    Saito H; Shioya M; Koie K; Kamiya T; Katsumi O
    Thromb Diath Haemorrh; 1969 Nov; 22(2):316-25. PubMed ID: 5380951
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII).
    Rizza CR; Edgcumbe JO; Pitney WR; Child JA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):120-8. PubMed ID: 5074988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.